Gabelli Funds LLC Has $2.56 Million Stake in Amrize Ltd $AMRZ

Gabelli Funds LLC increased its position in Amrize Ltd (NYSE:AMRZ) by 29.9% in the fourth quarter, HoldingsChannel reports. The firm owned 47,314 shares of the company’s stock after acquiring an additional 10,892 shares during the period. Gabelli Funds LLC’s holdings in Amrize were worth $2,559,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AMRZ. State of Wyoming acquired a new stake in shares of Amrize during the 3rd quarter valued at $32,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Amrize during the 4th quarter valued at $34,000. US Bancorp DE acquired a new stake in shares of Amrize during the 3rd quarter valued at $38,000. Costello Asset Management INC acquired a new stake in shares of Amrize during the 3rd quarter valued at $44,000. Finally, Jones Financial Companies Lllp acquired a new stake in shares of Amrize during the 3rd quarter valued at $53,000.

Insider Transactions at Amrize

In other news, CTO Roald Brouwer bought 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The shares were purchased at an average price of $58.72 per share, for a total transaction of $176,160.00. Following the acquisition, the chief technology officer directly owned 16,257 shares of the company’s stock, valued at $954,611.04. The trade was a 22.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Jan Philipp Jenisch bought 60,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of $58.05 per share, for a total transaction of $3,483,000.00. Following the acquisition, the chief executive officer directly owned 1,703,582 shares in the company, valued at approximately $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have purchased 129,554 shares of company stock worth $7,051,569. Corporate insiders own 0.54% of the company’s stock.

Amrize Stock Performance

Shares of AMRZ opened at $50.55 on Friday. The company has a market capitalization of $27.96 billion and a PE ratio of 24.19. Amrize Ltd has a one year low of $44.12 and a one year high of $65.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The company’s fifty day moving average price is $54.95 and its 200 day moving average price is $55.12.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $2.18 billion during the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company’s quarterly revenue was up 4.7% on a year-over-year basis. As a group, analysts expect that Amrize Ltd will post 2.71 earnings per share for the current year.

Amrize Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.

Analysts Set New Price Targets

AMRZ has been the subject of a number of research reports. Truist Financial decreased their target price on shares of Amrize from $75.00 to $65.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company decreased their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, April 15th. Weiss Ratings lowered shares of Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday. Berenberg Bank set a $70.00 target price on shares of Amrize in a research note on Thursday, February 19th. Finally, Morgan Stanley reissued an “overweight” rating and set a $65.00 target price on shares of Amrize in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and a consensus price target of $64.86.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.